BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38335290)

  • 1. CDCA7-associated global aberrant DNA hypomethylation translates to localized, tissue-specific transcriptional responses.
    Vukic M; Chouaref J; Della Chiara V; Dogan S; Ratner F; Hogenboom JZM; Epp TA; Chawengsaksophak K; Vonk KKD; Breukel C; Ariyurek Y; San Leon Granado D; Kloet SL; Daxinger L
    Sci Adv; 2024 Feb; 10(6):eadk3384. PubMed ID: 38335290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of specific DNA binding by the transcription factor ZBTB24.
    Ren R; Hardikar S; Horton JR; Lu Y; Zeng Y; Singh AK; Lin K; Coletta LD; Shen J; Lin Kong CS; Hashimoto H; Zhang X; Chen T; Cheng X
    Nucleic Acids Res; 2019 Sep; 47(16):8388-8398. PubMed ID: 31226215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.
    Woloszynska-Read A; Zhang W; Yu J; Link PA; Mhawech-Fauceglia P; Collamat G; Akers SN; Ostler KR; Godley LA; Odunsi K; Karpf AR
    Clin Cancer Res; 2011 Apr; 17(8):2170-80. PubMed ID: 21296871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the interaction between transcriptional intermediary factor 1{beta} and heterochromatin protein 1 leads to a switch from DNA hyper- to hypomethylation and H3K9 to H3K27 trimethylation on the MEST promoter correlating with gene reactivation.
    Riclet R; Chendeb M; Vonesch JL; Koczan D; Thiesen HJ; Losson R; Cammas F
    Mol Biol Cell; 2009 Jan; 20(1):296-305. PubMed ID: 18923144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CCCTC binding factor (CTCF) and cohesin in the generation of single-cell diversity of protocadherin-α gene expression.
    Monahan K; Rudnick ND; Kehayova PD; Pauli F; Newberry KM; Myers RM; Maniatis T
    Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9125-30. PubMed ID: 22550178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDCA7 and HELLS suppress DNA:RNA hybrid-associated DNA damage at pericentromeric repeats.
    Unoki M; Sharif J; Saito Y; Velasco G; Francastel C; Koseki H; Sasaki H
    Sci Rep; 2020 Oct; 10(1):17865. PubMed ID: 33082427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Daxx/Atrx Complex Protects Tandem Repetitive Elements during DNA Hypomethylation by Promoting H3K9 Trimethylation.
    He Q; Kim H; Huang R; Lu W; Tang M; Shi F; Yang D; Zhang X; Huang J; Liu D; Songyang Z
    Cell Stem Cell; 2015 Sep; 17(3):273-86. PubMed ID: 26340527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression.
    Kang JY; Song SH; Yun J; Jeon MS; Kim HP; Han SW; Kim TY
    Oncogene; 2015 Nov; 34(45):5677-84. PubMed ID: 25703332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.
    Velasco G; Grillo G; Touleimat N; Ferry L; Ivkovic I; Ribierre F; Deleuze JF; Chantalat S; Picard C; Francastel C
    Hum Mol Genet; 2018 Jul; 27(14):2409-2424. PubMed ID: 29659838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model.
    Borinstein SC; Conerly M; Dzieciatkowski S; Biswas S; Washington MK; Trobridge P; Henikoff S; Grady WM
    Mol Carcinog; 2010 Jan; 49(1):94-103. PubMed ID: 19777566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.
    Goto Y; Hayashi R; Muramatsu T; Ogawa H; Eguchi I; Oshida Y; Ohtani K; Yoshida K
    Biochim Biophys Acta; 2006; 1759(1-2):60-8. PubMed ID: 16580749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation in disease: Immunodeficiency, Centromeric instability, Facial anomalies syndrome.
    Vukic M; Daxinger L
    Essays Biochem; 2019 Dec; 63(6):773-783. PubMed ID: 31724723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
    Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
    Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer.
    Takai D; Gonzales FA; Tsai YC; Thayer MJ; Jones PA
    Hum Mol Genet; 2001 Nov; 10(23):2619-26. PubMed ID: 11726548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ZBTB24-CDCA7 axis regulates HELLS enrichment at centromeric satellite repeats to facilitate DNA methylation.
    Hardikar S; Ying Z; Zeng Y; Zhao H; Liu B; Veland N; McBride K; Cheng X; Chen T
    Protein Cell; 2020 Mar; 11(3):214-218. PubMed ID: 31970665
    [No Abstract]   [Full Text] [Related]  

  • 17. The structural complexity of the human BORIS gene in gametogenesis and cancer.
    Pugacheva EM; Suzuki T; Pack SD; Kosaka-Suzuki N; Yoon J; Vostrov AA; Barsov E; Strunnikov AV; Morse HC; Loukinov D; Lobanenkov V
    PLoS One; 2010 Nov; 5(11):e13872. PubMed ID: 21079786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTCF is the master organizer of domain-wide allele-specific chromatin at the H19/Igf2 imprinted region.
    Han L; Lee DH; Szabó PE
    Mol Cell Biol; 2008 Feb; 28(3):1124-35. PubMed ID: 18039862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of CTCF at the miR-125b1 locus in gynecological cancers.
    Soto-Reyes E; González-Barrios R; Cisneros-Soberanis F; Herrera-Goepfert R; Pérez V; Cantú D; Prada D; Castro C; Recillas-Targa F; Herrera LA
    BMC Cancer; 2012 Jan; 12():40. PubMed ID: 22277129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.
    Unoki M; Funabiki H; Velasco G; Francastel C; Sasaki H
    J Clin Invest; 2019 Jan; 129(1):78-92. PubMed ID: 30307408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.